Universe Pharmaceuticals (UPC) Change in Account Payables: 2021-2024
- Universe Pharmaceuticals' Change in Account Payables fell 39.77% to -$4.6 million in Q1 2024 from the same period last year, while for Mar 2024 it was -$277,359, marking a year-over-year increase of 13.66%. This contributed to the annual value of $143,747 for FY2024, which is 91.24% down from last year.
- As of Q1 2024, Universe Pharmaceuticals' Change in Account Payables stood at -$4.6 million, which was down 200.92% from $4.6 million recorded in Q3 2023.
- In the past 5 years, Universe Pharmaceuticals' Change in Account Payables ranged from a high of $5.3 million in Q3 2021 and a low of -$5.4 million during Q1 2022.
- Moreover, its 3-year median value for Change in Account Payables was -$3.3 million (2023), whereas its average is -$1.1 million.
- Its Change in Account Payables has fluctuated over the past 5 years, first tumbled by 42.09% in 2022, then surged by 49.10% in 2023.
- Universe Pharmaceuticals' Change in Account Payables (Quarterly) stood at $5.3 million in 2021, then plummeted by 42.09% to $3.1 million in 2022, then spiked by 49.10% to $4.6 million in 2023, then plummeted by 39.77% to -$4.6 million in 2024.
- Its Change in Account Payables was -$4.6 million in Q1 2024, compared to $4.6 million in Q3 2023 and -$3.3 million in Q1 2023.
